Pharmacists' attitudes towards the reporting of suspected adverse drug reactions in Norway
Authors:
- 5 September 2006
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 16 (4) , 429-434
Abstract
Background: In Scandinavian countries, pharmacists have not reported adverse drug reactions (ADRs), either due to legislative restrictions or because of lack of tradition. From 1 January 2005, Norwegian pharmacists have been encouraged by the Norwegian Medicines Agency to take a larger role in the reporting of ADRs.Objective: To explore pharmacists' attitudes towards pharmacovigilance and their experiences with ADR reporting, to evaluate the effect of an educational programme and to compare these findings to the attitudes in a control group.Methods: From September 2004, pharmacies in two of Norway's five health regions were invited to attend a 3‐month ADR reporting study, and 39 pharmacies were recruited. One pharmacist from each pharmacy participated in a 1 day pre‐study educational programme and a 1 day post‐study evaluation meeting. Pharmacists involved in the study answered a questionnaire (A) regarding their attitudes to ADR reporting (active group). A control group answered the same questionnaire. One reminder was sent. The active group evaluated the study by answering questionnaire A once more and an evaluation questionnaire (B). Qualitative aspects of ADR reporting were discussed with the active group post‐study.Results: The response rate for questionnaire A was 97% (n = 158) in the active group, 74% (n = 184) in the control group and the response rate for questionnaire A and B post‐study was 68% (n = 105) in the active group. Pharmacists in the active group had more positive attitudes to ADR reporting after taking part in the study than the control group (p < 0.001). Lack of time, confidence and knowledge of reporting rules could potentially prevent them from reporting ADRs.Conclusions: The pharmacists had positive attitudes towards pharmacovigilance, but very little experience with reporting. The educational programme clarified their role and increased their knowledge about the reporting requirements. Copyright © 2006 John Wiley & Sons, Ltd.Keywords
This publication has 19 references indexed in Scilit:
- A distance‐learning programme in pharmacovigilance linked to educational credits is associated with improved reporting of suspected adverse drug reactions via the UK yellow card schemeBritish Journal of Clinical Pharmacology, 2005
- The role of hospital and community pharmacists in pharmacovigilanceResearch in Social and Administrative Pharmacy, 2005
- Pharmacists' role in reporting adverse drug reactions in an international perspectivePharmacoepidemiology and Drug Safety, 2003
- Attitudes of community pharmacists in the Netherlands towards adverse drug reaction reportingInternational Journal of Pharmacy Practice, 2002
- Contribution of pharmacists to the reporting of adverse drug reactionsPharmacoepidemiology and Drug Safety, 2002
- Adverse drug reactions as a cause for admissions to a department of internal medicinePharmacoepidemiology and Drug Safety, 2002
- Attitudes and knowledge of hospital pharmacists to adverse drug reaction reportingBritish Journal of Clinical Pharmacology, 2001
- Attitudes of hospital pharmacists to adverse drug reactions and the “yellow card” scheme: a qualitative studyInternational Journal of Pharmacy Practice, 1999
- Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom [see comments]British Journal of Clinical Pharmacology, 1995
- The Role Of Pharmacists in Adverse Drug Reaction ReportingDrug Safety, 1994